BIOS logo

BioPlus Acquisition Corp. Stock Price

NasdaqGM:BIOS Community·US$209.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BIOS Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

BIOS Community Narratives

There are no narratives available yet.

Recent BIOS News & Updates

BioPlus Acquisition Corp. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

-US$5.8m

Other Expenses

US$5.8m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.30
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
-39.6%

BioPlus Acquisition Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Questionable track record with weak fundamentals.

4 Risks
1 Reward

About BIOS

Founded
2021
Employees
n/a
CEO
R. Ross Haghighat
WebsiteView website
bioplusspac.com

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
The Healthcare sector gained 3.7% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. Earnings are forecast to grow by 15% annually. Market details ›